The United States leads the global mortality rate for pancreas malignant neoplasms with 49.69 thousand deaths forecasted in 2024, followed by Japan and Germany with 40.67 and 20.24 thousand deaths respectively. Brazil and the United Kingdom show notable figures too, at 13.51 and 10.42 thousand deaths. The overall year-on-year variation for 2023 illustrates a rising trend in most of the countries, with the highest percentage increase observed in Peru (6.62%) and Iceland (5.75%), indicating a growing concern.
Over the last five years, the Compound Annual Growth Rate (CAGR) indicates consistent growth in mortality rates, pointing to an escalating global health challenge related to pancreatic cancer.
Future trends to watch for:
- High-impact measures and interventions in countries with rapidly increasing mortality rates.
- Variations due to emerging healthcare technologies, early diagnosis, and treatment innovations.
- Potential shifts in country rankings based on public health policy effectiveness and medical advancements.
Top countries in Pancreas Malignant Neoplasms Mortality by Country
| # | 10 Countries | Units (Deaths) | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 United States | 49,690 | 2023 | +1.94% | +2.04% | View data |
| 2 | 2 Japan | 40,670 | 2023 | +2.53% | +2.8% | View data |
| 3 | 3 Germany | 20,240 | 2023 | +1.75% | +2% | View data |
| 4 | 4 Brazil | 13,510 | 2023 | +3.59% | +4.01% | View data |
| 5 | 5 United Kingdom | 10,420 | 2023 | +1.6% | +1.71% | View data |
| 6 | 6 Spain | 8,030 | 2023 | +2.37% | +2.43% | View data |
| 7 | 7 South Korea | 7,500 | 2023 | +3.85% | +4.44% | View data |
| 8 | 8 Canada | 5,590 | 2023 | +1.65% | +1.69% | View data |
| 9 | 9 Mexico | 5,310 | 2023 | +3.15% | +3.33% | View data |
| 10 | 10 Poland | 5,180 | 2023 | +1.03% | +0.7% | View data |
